Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages

Vascular Pharmacology

Volumn 47, Issue 2-3, 2007, Pages 99-107

  Kim, Kyung Woon ^a   Ha, Ki Tai ^b   Park, Cheol Soo ^a   Jin, Un Ho ^a   Chang, Hyen Wook ^c   Lee, In Seon ^d   Kim, Cheorl Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b Dongguk University   (South Korea)

^c Yeungnam University   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

Baicalin; Berberine; Cyclooxygenase 2; Inducible nitric oxide synthase; Lipopolysaccharide; Polygonum cuspidatum

Indexed keywords

BAICALIN; BERBERINE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; PLANT EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BERBERINE; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROARGININE; PHELLODENDRON; PLANT EXTRACTS; POLYGONUM CUSPIDATUM; SCUTELLARIA BAICALENSIS;

EID: 34447621559     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.04.007     Document Type: Article

References (32)

1. Chen Y.C., Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Elevation of apoptotic potential by anoxia hyperoxia shift in NIH3T3 cells. Mol. Cell. Biochem. 197 (1999) 147-159
2. Chen L., Han Y., Yang F., and Zhang T. High-speed counter-current chromatography separation and purification of resveratrol and piceid from Polygonum cuspidatum. J. Chromatogr., A. 907 (2001) 343-346
3. Chen Y.C., Lin-Shiau S.Y., and Lin J.K. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expression induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61 (2001) 1417-1427
4. Choi J., Conrad C.C., Malakowsky C.A., Talent J.M., Yuan C.S., and Gracy R.W. Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines. Biochim. Biophys. Acta 1571 (2002) 201-210
5. Duval D.L., Miller D.R., Collier J., and Billings R.E. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol. Pharmacol. 50 (1996) 277-284
6. Evans C.H. Nitric oxide: what role does it play in inflammation and tissue destruction?. Agents Actions Suppl. 47 (1995) 107-116
7. Hartner A., Goppelt-Struebe M., and Hilgers K.F. Coordinate expression of cyclooxygenase-2 and rennin in the rat kidney in renovascular hypertension. Hypertension 31 Suppl 2 (1998) 201-205
8. Hawkey C.J. Cox-2 inhibitors. Lancet 353 (1999) 307-314
9. Kim H., Lee H.S., Chang K.T., Ko T.H., Baek K.J., and Kwon N.S. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-B. J. Immunol. 154 (1995) 4741-4748
10. Koyanagi M., Egashira K., Kubo-Inoue M., Usni M., Kitamoto S., Tomita H., Shimokawa H., and Takeshita A. Role of transforming growth factor-1 in cardiovascular inflammatory changes by chronic inhibition of nitric oxide synthesis. Hypertension 35 (2000) 86-90
11. Lee D.U., Kang Y.J., Park M.K., Lee Y.S., Seo H.G., Kim T.S., Kim C.H., and Chang K.C. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 73 (2003) 1401-1412
12. Lee H.S., Eom Y.E., and Eom D.O. Narrowbore high performance liquid chromatography of berberine and palmatine in crude drugs and pharmaceuticals with ion-pair extraction using cobalt thiocyanate reagent. Pharm. Biomed. Anal. 21 (1999) 59-63
13. Levy G.N. Prostaglandin H synthases, non-steroidal anti-inflammatory drugs and colon cancer. FASEB J. 11 (1997) 234-247
14. Lin J.K., Liang Y.C., and Lin-Shiau S.Y. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58 (1998) 911-915
15. Liu R.H., and Motchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 339 (1995) 73-89
16. Mao T., Yan Q., Zhou F., and Shen Y. Isolation and identification of berberine from cell cultures of Coptis chinensis. Chin. J. Biotechnol. 13 (1997) 193-199
17. Matsuda H., Shimoda H., Morikawa T., and Yoshikawa M. Phytoestrogens from the roots of Polygonum cuspidatum (polygonaceae): structure-requirement of ydroxyanthraquinones for estrogenic activity. Bioorg. Med. Chem. Lett. 11 (2001) 1839-1842
18. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q.W., Nathan C., and Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178 (1993) 749-754
19. Moncada S., Palmer R.M., and Higgs D.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43 (1992) 109-142
20. Misaki T., Sagara K., Ojima M., Kakizawa S., Oshima T., and Yoshizawa H. Simultaneous determination of berberine, palmatine and coptisine in crude drugs and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. Chem. Pharm. Bull. 30 (1982) 354-357
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
22. Nathan C., and Xie Q.W. Nitric oxide synthases: roles, tolls and controls. Cell 78 (1994) 915-918
23. Park J.I., Shim J.K., Do J.W., Kim S.Y., Seo E.K., Kwon H.J., Lee T.K., Kim J.K., Choi D.Y., and Kim C.H. Immune-stimulating properties of polysaccharides from Phellodendri cortex (Hwangbek). Glycoconj. J. 16 (1999) 247-252
24. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit W.E., Xie Q.E., Nathan C., Gribble G.W., and Sporn M.N. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58 (1998) 717-723
25. Thiemermann C., and Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182 (1990) 591-595
26. Tunctan B., Uludag O., Altug S., and Abacioglu N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol. Res. 38 (1998) 405-411
27. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
28. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., and Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor. J. Exp. Med. 178 (1993) 605-613
29. Wong S.C., Fukuchi M., Melnyk P., Rodger I., and Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor B in myocardium of patients with congestive heart failure. Circulation 98 (1998) 100-103
30. Yang F., de Villiers W.J., McClain C.J., and Varilek G.W. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128 (1998) 2334-2340
31. Yoshikawa M., Uemura T., Shimoda H., Kishi A., Kawahara K., and Matsuda H. Medicinal foodstuffs. XVIII. Phytoestrogens from the aerial part of Petroselinum crispum MIll. (Parsley) and structures of 6″-acetylapiin and a new monoterpene glycoside, petroside. Chem. Pharm. Bull. 48 (2000) 1039-1044
32. Zeineddine N.S., Avina M.D., Williams C.C., Wepsic H.T., and Jadus M.R. Macrophages that kill glioma cells expressing the membrane form of macrophage colony stimulating factor are resistant to prostaglandin E2 and interleukin-10. Immunol. Lett. 70 (1999) 63-68